Roche Revamps to Cut Costs, Slashes 4,800 Jobs; Sells U.S. Factories

ZURICH, Nov 17 (Reuters) - Roche Holding AG (ROG.VX) set out plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring programme as it grapples with recent product setbacks and mounting pressure on prices.